Etienne Delgrange Selected Research

Etienne Delgrange Research Topics

4	Prolactinoma (Prolactinomas) 06/2014 - 04/2006
3	Neoplasms (Cancer) 01/2018 - 05/2009
2	Pituitary Neoplasms (Pituitary Adenoma) 06/2015 - 06/2014
1	Graves Disease (Basedow Disease) 01/2021
1	Hyperthyroidism 01/2021
1	Immune System Diseases (Immune Disorders) 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2019
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2018
1	Hypothyroidism 02/2017
1	Disease Progression 06/2015
1	Endocrine System Diseases (Endocrine Diseases) 06/2014
1	Neurologic Manifestations (Neurological Manifestations) 06/2014
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2006

6	Dopamine Agonists (Dopamine Agonist)IBA 01/2018 - 04/2006
3	ProlactinIBA 06/2015 - 05/2009
2	Estrogen Receptor alphaIBA 01/2018 - 06/2015
2	Cabergoline FDA LinkGeneric 05/2009 - 01/2006
1	CytokinesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	mRNA VaccinesIBA 01/2021
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	fibroblast growth factor 13IBA 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	Vascular Endothelial Growth Factor DIBA 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 02/2017
1	TabletsIBA 02/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2014

3	Therapeutics 06/2015 - 04/2006
1	Contraception (Birth Control) 11/2018
1	Bariatric Surgery 02/2017